Latvia · Venture startup

Who invested in MolPort

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechChemicals & Materials

Funding summaryUpdated 7 Nov 2026

$766Kraised across 2 rounds since 2010, from 2 sources

$132KSeed$633KVenture
Latest round
Venture, $633KApr 2013
Step-upi
4.8×
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201120122013
$132KSeed$633KVenture
First round
Seed, $132K
Dec 2010
Biggest round
$633K
Venture · Apr 2013
Between rounds
2.3 years
from the last two

The rounds

  1. Apr 2013
    Venture$633K1 new1 returning

    From a historical funding record

  2. Dec 2010
    Seed$132K1 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2010Venture2013Imprimatur CapitalFlyCap

Everyone who backed them

Imprimatur CapitalVC firm2rounds
FlyCapVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about MolPort

Who invested in MolPort?

MolPort's investors include Imprimatur Capital and FlyCap.

How much has MolPort raised?

MolPort has raised $766K across 2 rounds since 2010.

When did MolPort last raise?

MolPort's most recent round was a Venture of $633K in Apr 2013.

What was MolPort's biggest round?

Its most recent round, $633K in Apr 2013, is also its largest on record.

Who backed MolPort first?

MolPort's first round on record, in Dec 2010, was backed by Imprimatur Capital.

What stage is MolPort at?

MolPort's latest named round is a Venture, in Apr 2013.

Where is MolPort based?

MolPort is based in Latvia.

Companies like MolPort

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.